The_DT
human_JJ
TCF-1_NN
gene_NN
encodes_VBZ
a_DT
nuclear_JJ
DNA-binding_JJ
protein_NN
uniquely_RB
expressed_VBN
in_IN
normal_JJ
and_CC
neoplastic_JJ
T-lineage_JJ
lymphocytes_NNS
._.

The_DT
TCF-1_NN
gene_NN
encodes_VBZ
a_DT
putative_JJ
transcription_NN
factor_NN
with_IN
affinity_NN
for_IN
a_DT
sequence_NN
motif_NN
occurring_VBG
in_IN
a_DT
number_NN
of_IN
T-cell_NN
enhancers_NNS
._.

TCF-1_NN
mRNA_NN
was_VBD
originally_RB
found_VBN
to_TO
be_VB
expressed_VBN
in_IN
a_DT
T_NN
cell-specific_JJ
fashion_NN
within_IN
a_DT
set_NN
of_IN
human_JJ
and_CC
mouse_NN
cell_NN
lines_NNS
._.

In_IN
contrast_NN
,_,
expression_NN
reportedly_RB
occurs_VBZ
in_IN
multiple_JJ
nonlymphoid_JJ
tissues_NNS
during_IN
murine_JJ
embryogenesis_NN
._.

We_PRP
have_VBP
now_RB
raised_VBN
a_DT
monoclonal_JJ
antibody_NN
to_TO
document_VB
expression_NN
and_CC
biochemistry_NN
of_IN
the_DT
human_JJ
TCF-1_NN
protein_NN
._.

As_IN
expected_VBN
,_,
the_DT
TCF-1_NN
protein_NN
was_VBD
detectable_JJ
only_RB
in_IN
cell_NN
lines_NNS
of_IN
T_NN
lineage_NN
._.

Its_PRP$
expression_NN
was_VBD
always_RB
restricted_JJ
to_TO
the_DT
nucleus_NN
._.

Immunohistochemistry_NN
on_IN
a_DT
panel_NN
of_IN
human_JJ
tissues_NNS
revealed_VBD
that_IN
the_DT
TCF-1_NN
protein_NN
was_VBD
found_VBN
exclusively_RB
in_IN
thymocytes_NNS
and_CC
in_IN
CD3_NN
+_CC
T_NN
cells_NNS
in_IN
peripheral_JJ
lymphoid_JJ
tissues_NNS
._.

Western_NN
blotting_NN
yielded_VBD
a_DT
set_NN
of_IN
bands_NNS
ranging_VBG
from_IN
25_CD
kD_NN
to_TO
55_CD
kD_NN
,_,
resulting_VBG
from_IN
extensive_JJ
alternative_JJ
splicing_NN
._.

The_DT
TCF-1_NN
protein_NN
was_VBD
detectable_JJ
in_IN
all_DT
samples_NNS
of_IN
a_DT
set_NN
of_IN
22_CD
T-cell_NN
malignancies_NNS
of_IN
various_JJ
stages_NNS
of_IN
maturation_NN
,_,
but_CC
was_VBD
absent_JJ
from_IN
a_DT
large_JJ
number_NN
of_IN
other_JJ
hematologic_JJ
neoplasms_NNS
._.

These_DT
observations_NNS
imply_VBP
a_DT
T_NN
cell-specific_JJ
function_NN
for_IN
TCF-1_NN
,_,
a_DT
notion_NN
corroborated_VBN
by_IN
recent_JJ
observations_NNS
on_IN
Tcf-1_NN
knock-out_JJ
mice_NNS
._.

In_IN
addition_NN
,_,
these_DT
results_NNS
indicate_VBP
that_IN
nuclear_JJ
TCF-1_NN
expression_NN
can_MD
serve_VB
as_IN
a_DT
pan-T-lineage_JJ
marker_NN
in_IN
the_DT
diagnosis_NN
of_IN
lymphoid_JJ
malignancies_NNS
._.

